DGX's Income from Cont. Operations Growth by Quarter and Year

Quest Diagnostics Inc's Income from Cont. Operations results by quarter and year

Select the Comparisons :

None ▼

Select the Ratio:

Income from Cont. Operations Growth Y/Y▼

None ▼

Income from Cont. Operations Growth Y/Y▼

DGX Income from Cont. Operations (in millions $)		FY 2021	FY 2020	FY 2019	FY 2018
IV Quarter	December	-	609.00	265.00	197.00
III Quarter	September	-	591.00	226.00	227.00
II Quarter	June	-	193.00	219.00	233.00
I Quarter	March	490.00	106.00	176.00	189.00
FY		490.00	1,499.00	886.00	846.00

DGX Income from Cont. Operations first quarter 2021 Y/Y Growth Comment

Quest Diagnostics Inc achieved in the first quarter, above Company average Income from Cont. Operations surge of 362.26% year on year, to $ 490.00 millions.

Among companies who have reported first quarter results in the Medical Laboratories industry only one Company has achieved higher year on year Income from Cont. Operations results in the first quarter. While Quest Diagnostics Inc' s Income from Cont. Operations doubling of 362.26% ranks overall at the positon no. 42 in the first quarter.

DGX Income from Cont. Operations ( Y/Y Growth %)		2021	2020	2019	2018
IV Quarter	December	-	129.81 %	34.52 %	-26.22 %
III Quarter	September	-	161.5 %	-0.44 %	29.71 %
II Quarter	June	-	-11.87 %	-6.01 %	12.56 %
I Quarter	March	362.26 %	-39.77 %	-6.88 %	8 %
FY		-	69.19 %	4.73 %	2.67 %

Financial Statements
Quest Diagnostics Inc's first quarter 2021 Income from Cont. Operations	$ 490.00 millions	DGX's Income Statement
Quest Diagnostics Inc's first quarter 2020 Income from Cont. Operations	$ 106.00 millions	Quarterly DGX's Income Statement
New: More DGX's historic Income from Cont. Operations Growth >>

DGX Income from Cont. Operations (Quarter on Quarter Growth %)		2021	2020	2019	2018
IV Quarter	December	-	3.05 %	17.26 %	-13.22 %
III Quarter	September	-	206.22 %	3.2 %	-2.58 %
II Quarter	June	-	82.08 %	24.43 %	23.28 %
I Quarter	March	-19.54 %	-60 %	-10.66 %	-29.21 %
FY (Year on Year)		-	69.19 %	4.73 %	2.67 %

Current DGX Income Statement >> Back to DGX Growth rate Comparisons >>

Income from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within:	No.
Medical Laboratories Industry	#2
Healthcare Sector	#2
Overall	#42

Income from Cont. Operations Y/Y Growth Statistics
High	Average	Low
46.2 %	3.1 %	-33.42 %
(Sep 30 2020)		(Sep. 30, 2014)

Income from Cont. Operations first quarter 2021 Y/Y Growth Company Ranking
Within:	No.
Medical Laboratories Industry	#2
Healthcare Sector	#2
Overall	#42

Income from Cont. Operations Y/Y Growth Statistics
High	Average	Low
46.2 %	3.1 %	-33.42 %
(Sep 30 2020)		(Sep. 30, 2014)

Income from Cont. Operations by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Quest Diagnostics Inc's Q/Q Income from Cont. Operations Growth

Income from Cont. Operations Q/Q Growth Statistics
High	Average	Low
206.22 %	9.56 %	-64.1 %
(Sep 30 2020)

DGX's I. Quarter Q/Q Income from Cont. Operations Comment

In the I. Quarter 2021 Quest Diagnostics Inc reported fall in Income from Cont. Operations from the previous quarter by -19.54% to $ 490.00 millions, from $ 609.00 millions declared a quarter before.

If you look into present shortcoming in the I. Quarter 2021, you suppose to take into consideration, that commonly I. Quarter performance occur sluggish in contrast to the quarter before, Lucia Russo, Healthcare sector contributor based in Zurich said.

Within Medical Laboratories industry only one company achieved higher sequential Income from Cont. Operations growth. While Quest Diagnostics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 107.

Income from Cont. Operations Q/Q Growth Company Ranking
Within:	No.
Medical Laboratories Industry	#2
Healthcare Sector	#7
Overall	#107

Income from Cont. Operations Q/Q Growth Company Ranking
Within:	No.
Medical Laboratories Industry	#2
Healthcare Sector	#7
Overall	#107

Income from Cont. Operations Q/Q Growth Statistics
High	Average	Low
206.22 %	9.56 %	-64.1 %
(Sep 30 2020)

DGX's I. Quarter Q/Q Income from Cont. Operations Comment

In the I. Quarter 2021 Quest Diagnostics Inc realized fall in Income from Cont. Operations sequentially by -19.54% to $ 490.00 millions, from $ 609.00 millions released in the previous quarter.

This is not huge problem, as I. Quarter Income from Cont. Operations always gravitate to plunge in this quarter.

Within Medical Laboratories industry only one company achieved higher sequential Income from Cont. Operations growth. While Quest Diagnostics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 107.

Quest Diagnostics Inc's 12 Months Income from Cont. Operations Growth Year on Year

Income from Cont. Operations TTM Growth	12 Months Ending (Mar 31 2021)	12 Months Ending (Dec 31 2020)	12 Months Ending (Sep 30 2020)	12 Months Ending (Jun 30 2020)	12 Months Ending (Mar 31 2020)
Cumulative Income from Cont. Operations 12 Months Ending	$ 1,883.00	$ 1,499.00	$ 1,155.00	$ 790.00	$ 816.00
Y / Y Income from Cont. Operations Growth (TTM)	130.76 %	69.19 %	41.2 %	-3.54 %	-2.04 %
Year on Year Income from Cont. Operations Growth Overall Ranking	# 165	# 339	# 422	# 940	# 1048
Seqeuential Income from Cont. Operations Change (TTM)	25.62 %	29.78 %	46.2 %	-3.19 %	-7.9 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking	# 42	# 155	# 251	# 1061	# 534

New: More DGX's historic Income from Cont. Operations Growth >>

Cumulative Income from Cont. Operations growth Comment

With 130.76% annual Income from Cont. Operations growth, Quest Diagnostics Inc would report a record annual Income from Cont. Operations surge if the fiscal year would end on Mar 31 2021.

Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 165, from total ranking in previous quarter at 339.

Income from Cont. Operations TTM Q/Q Growth Statistics
High	Average	Low
46.2 %	3.1 %	-33.42 %

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within:	No.
Medical Laboratories Industry	# 2
Healthcare Sector	# 19
Overall	# 165

Income from Cont. Operations TTM Y/Y Growth Statistics
High	Average	Low
130.76 %	8.81 %	-35.86 %
(Mar 31 2021)

Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within:	No.
Industry	# 2
Sector	# 2
S&P 500	# 42

Cumulative Income from Cont. Operations growth Comment

Income from Cont. Operations TTM Q/Q Growth Statistics
High	Average	Low
46.2 %	3.1 %	-33.42 %

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within:	No.
Medical Laboratories Industry	# 2
Healthcare Sector	# 19
Overall	# 165

Income from Cont. Operations TTM Y/Y Growth Statistics
High	Average	Low
130.76 %	8.81 %	-35.86 %
(Mar 31 2021)

Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within:	No.
Industry	# 2
Sector	# 2
S&P 500	# 42

Other Income from Cont. Operations Growth
Medical Laboratories Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
DGX's Income from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for DGX's Competitors
Income from Cont. Operations Growth for Quest Diagnostics Inc's Suppliers
Income from Cont. Operations Growth for DGX's Customers

You may also want to know
DGX's Annual Growth Rates	DGX's Profitability Ratios	DGX's Asset Turnover Ratio	DGX's Dividend Growth
DGX's Roe	DGX's Valuation Ratios	DGX's Financial Strength Ratios	DGX's Dividend Payout Ratio
DGX's Roa	DGX's Inventory Turnover Ratio	DGX's Growth Rates	DGX's Dividend Comparisons

Companies with similar Income from Cont. Operations surge for the quarter ending Mar 31 2021 within Healthcare Sector	Y/Y Change %	Income from Cont. Operations for the quarter ending Mar 31 2021
Hologic Inc	543.72%	$ 543.718 millions
Surmodics Inc	453.15%	$ 453.146 millions
Integra Lifesciences Holdings Corp	394.49%	$ 394.488 millions
Apollo Medical Holdings Inc	384.03%	$ 384.031 millions
Quest Diagnostics Inc	362.26%	$ 362.264 millions
Quidel Corporation	342.59%	$ 342.588 millions
Progyny Inc	273.82%	$ 273.823 millions
Avantor Inc	248.94%	$ 248.936 millions
Teva Pharmaceutical Industries Ltd	236.00%	$ 236.000 millions
Abbott Laboratories	229.60%	$ 229.596 millions
Repligen Corp	200.05%	$ 200.051 millions
Reynolds Consumer Products Inc	184.62%	$ 184.615 millions

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar GTN's Profile Stock Price GTN's Financials Business Description Fundamentals Charts & Quotes GTN's News Suppliers GTN's Competitors Customers & Markets Economic Indicators GTN's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

DGX's Income from Cont. Operations Growth by Quarter and Year

DGX Income from Cont. Operations (Quarter on Quarter Growth %)

Income from Cont. Operations TTM Growth